IL6 and chronic obstructive pulmonary disease: Foamy macrophages, lipid-laden immune cells prevalent in the lungs of COPD patients, particularly smokers, exacerbate disease progression by releasing pro-inflammatory cytokines (e.g., IL-6, TNF-α) and ROS, contributing to alveolar destruction [5,6].